Ratz C
Urologie Groß-Gerau, Am Sandböhl 2, 64521, Groß-Gerau, Deutschland.
Urologe A. 2019 Mar;58(3):284-290. doi: 10.1007/s00120-019-0861-1.
Use of vaginal laser therapy in the treatment of grade I stress urinary incontinence and genitourinary syndrome of menopause is gaining in importance across the globe.
On the basis of the research that is currently available, an analysis is carried out regarding whether laser therapy is already suitable for use in the field of urology.
The research available is still limited: randomized controlled studies in particular are lacking. All the data published to date demonstrate a response to laser therapy with minimal side effects, high patient compliance and satisfaction, and a long-term response for a minimum of 12 months.
Vaginal laser therapy has shown potential and demonstrated its safety for use in urology as either a complementary or alternative treatment to existing treatment options, such as topical hormonal therapies, pelvic floor exercises or surgical procedures. It is necessary to define it as separate from aesthetic procedures.
阴道激光疗法在治疗I度压力性尿失禁和绝经后泌尿生殖综合征方面，在全球范围内的重要性日益增加。
基于目前可得的研究，对激光疗法是否已适用于泌尿外科领域进行分析。
现有研究仍然有限：尤其缺乏随机对照研究。迄今发表的所有数据均表明，激光疗法有疗效，副作用极小，患者依从性和满意度高，且有至少12个月的长期疗效。
阴道激光疗法已显示出潜力，并证明了其在泌尿外科作为现有治疗选择（如局部激素疗法、盆底肌锻炼或外科手术）的补充或替代治疗的安全性。有必要将其与美容手术区分开来。
